Suscribirse

Syncope Risk Stratification Tools vs Clinical Judgment: An Individual Patient Data Meta-analysis - 21/11/14

Doi : 10.1016/j.amjmed.2014.05.022 
Giorgio Costantino, MD a, , Giovanni Casazza, PhD b, Matthew Reed, MD c, Ilaria Bossi, MD a, Benjamin Sun, MD d, Attilio Del Rosso, MD e, Andrea Ungar, MD f, Shamai Grossman, MD g, Fabrizio D'Ascenzo, MD h, James Quinn, MD i, Daniel McDermott, MD j, Robert Sheldon, MD k, Raffaello Furlan, MD l
a Medicina fisiopatologica, Dipartimento di Medicina Interna, Osp. L. Sacco, Milano, Italy 
b Dipartimento di Scienze Biomediche e Cliniche “L. Sacco” - Università degli Studi di Milano, Milano, Italy 
c Emergency Medicine Research Group Edinburgh, Royal Infirmary of Edinburgh, UK 
d Department of Emergency Medicine, Oregon Health and Science University, Portland 
e Electrophysiology Unit, Cardiology Division, Department of Medicine, Ospedale S. Giuseppe, Empoli, Italy 
f Syncope Unit, Geriatric Cardiology and Medicine, Azienda Ospedaliero Universitaria Careggi and University of Florence, Firenze, Italy 
g Department of Emergency Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Mass 
h Divisione di Cardiologia, Università degli Studi di Torino, Torino, Italy 
i Division of Emergency Medicine, Stanford University School of Medicine, Calif 
j Division of Emergency Medicine, University of California, San Francisco 
k Libin Cardiovascular Institute of Alberta, Calgary, Canada 
l Internal Medicine, University of Milan, Humanitas Clinical and Research Center, Rozzano (MI), Italy 

Requests for reprints should be addressed to Giorgio Costantino, MD, Medicina Fisiopatologica, Azienda Ospedaliera L. Sacco, Università degli Studi di Milano, Via GB Grassi 74, Milano 20157, Italy.

Abstract

Background

There have been several attempts to derive syncope prediction tools to guide clinician decision-making. However, they have not been largely adopted, possibly because of their lack of sensitivity and specificity. We sought to externally validate the existing tools and to compare them with clinical judgment, using an individual patient data meta-analysis approach.

Methods

Electronic databases, bibliographies, and experts in the field were screened to find all prospective studies enrolling consecutive subjects presenting with syncope to the emergency department. Prediction tools and clinical judgment were applied to all patients in each dataset. Serious outcomes and death were considered separately during emergency department stay and at 10 and 30 days after presenting syncope. Pooled sensitivities, specificities, likelihood ratios, and diagnostic odds ratios, with 95% confidence intervals, were calculated.

Results

Thirteen potentially relevant papers were retrieved (11 authors). Six authors agreed to share individual patient data. In total, 3681 patients were included. Three prediction tools (Osservatorio Epidemiologico sulla Sincope del Lazio [OESIL], San Francisco Syncope Rule [SFSR], Evaluation of Guidelines in Syncope Study [EGSYS]) could be assessed by the available datasets. None of the evaluated prediction tools performed better than clinical judgment in identifying serious outcomes during emergency department stay, and at 10 and 30 days after syncope.

Conclusions

Despite the use of an individual patient data approach to reduce heterogeneity among studies, a large variability was still present. Current prediction tools did not show better sensitivity, specificity, or prognostic yield compared with clinical judgment in predicting short-term serious outcome after syncope. Our systematic review strengthens the evidence that current prediction tools should not be strictly used in clinical practice.

El texto completo de este artículo está disponible en PDF.

Keywords : Individual patient data, Meta-analysis, Prognosis, Risk-stratification tools, Rules, Syncope


Esquema


 Funding: None.
 Conflicts of Interest: None.
 Authorship: All authors have taken due care to ensure the integrity of the work, meet authorship criteria and have seen and approved the manuscript.


© 2014  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 127 - N° 11

P. 1126.e13-1126.e25 - novembre 2014 Regresar al número
Artículo precedente Artículo precedente
  • Balloon Mitral Valvuloplasty in the United States: A 13-Year Perspective
  • Apurva O. Badheka, Neeraj Shah, Abhijit Ghatak, Nileshkumar J. Patel, Ankit Chothani, Kathan Mehta, Vikas Singh, Nilay Patel, Peeyush Grover, Abhishek Deshmukh, Sidakpal S. Panaich, Ghanshyambhai T. Savani, Vipulkumar Bhalara, Shilpkumar Arora, Ankit Rathod, Harit Desai, Saibal Kar, Carlos Alfonso, Igor F. Palacios, Cindy Grines, Theodore Schreiber, Charanjit S. Rihal, Raj Makkar, Mauricio G. Cohen, William O'Neill, Eduardo de Marchena
| Artículo siguiente Artículo siguiente
  • Zoledronic Acid in Osteoporosis Secondary to Mastocytosis
  • Maurizio Rossini, Roberta Zanotti, Ombretta Viapiana, Gaia Tripi, Luca Idolazzi, Marta Biondan, Giovanni Orsolini, Patrizia Bonadonna, Silvano Adami, Davide Gatti

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.